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Clinical PerspectiveWhat Is New?Bilateral transcutaneous electrical stimulation applied over the common peroneal nerve enhanced the efficacy of lower limb task‐oriented training in people with chronic stroke.Bilateral transcutaneous electrical stimulation is better than unilateral transcutaneous electrical stimulation in improving the paretic ankle dorsiflexor strength (1 of 4 prespecified primary outcomes) and Timed Up and Go Test completion time.There were no differences in the other 3 primary outcomes.What Are the Clinical Implications?The training effects of both intervention protocols last for at least 3 months after the end of training, except for the paretic ankle plantarflexor strength.

Introduction {#jah32954-sec-0009}
============

Transcutaneous electrical nerve stimulation (TENS) is used as an adjunct treatment to enhance paretic lower‐limb muscle strength,[1](#jah32954-bib-0001){ref-type="ref"}, [2](#jah32954-bib-0002){ref-type="ref"}, [3](#jah32954-bib-0003){ref-type="ref"} walking speed,[3](#jah32954-bib-0003){ref-type="ref"}, [4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"}, [6](#jah32954-bib-0006){ref-type="ref"} balance performance,[2](#jah32954-bib-0002){ref-type="ref"}, [3](#jah32954-bib-0003){ref-type="ref"}, [7](#jah32954-bib-0007){ref-type="ref"} and functional mobility[1](#jah32954-bib-0001){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"}, [7](#jah32954-bib-0007){ref-type="ref"}, [8](#jah32954-bib-0008){ref-type="ref"} in subjects with acute,[1](#jah32954-bib-0001){ref-type="ref"} subacute,[6](#jah32954-bib-0006){ref-type="ref"}, [7](#jah32954-bib-0007){ref-type="ref"} and chronic[2](#jah32954-bib-0002){ref-type="ref"}, [4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} stroke. The therapeutic effects of TENS may be mediated via peripheral[9](#jah32954-bib-0009){ref-type="ref"}, [10](#jah32954-bib-0010){ref-type="ref"}, [11](#jah32954-bib-0011){ref-type="ref"} and central mechanisms.[12](#jah32954-bib-0012){ref-type="ref"}, [13](#jah32954-bib-0013){ref-type="ref"} At the peripheral level, TENS applied over paretic legs reduced the amplitude of the H‐reflex[9](#jah32954-bib-0009){ref-type="ref"} and lengthened the stretch reflex latency[10](#jah32954-bib-0010){ref-type="ref"} and H‐reflex latency[11](#jah32954-bib-0011){ref-type="ref"} in subjects with chronic stroke. At the cortical level, a single session of cutaneous electrical stimulation applied over a paretic hand reduced short‐interval intracortical inhibition[12](#jah32954-bib-0012){ref-type="ref"} and enhanced cortical‐muscular coupling during paretic thumb contraction.[13](#jah32954-bib-0013){ref-type="ref"} Previous studies from our laboratory[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} showed that 20 sessions of unilateral TENS (Uni‐TENS) applied over the paretic legs combined with task‐oriented training (TOT) led to greater improvement in lower‐limb muscle strength and walking performance than placebo‐TENS combined with TOT in subjects with chronic stroke.

Clinical studies have consistently demonstrated that bilateral motor training is beneficial[14](#jah32954-bib-0014){ref-type="ref"} and superior to unilateral or conventional training for the recovery of motor control,[15](#jah32954-bib-0015){ref-type="ref"}, [16](#jah32954-bib-0016){ref-type="ref"} muscle strength,[15](#jah32954-bib-0015){ref-type="ref"} the kinematics of upper limb movement,[16](#jah32954-bib-0016){ref-type="ref"}, [17](#jah32954-bib-0017){ref-type="ref"}, [18](#jah32954-bib-0018){ref-type="ref"} hand dexterity,[15](#jah32954-bib-0015){ref-type="ref"} and upper‐limb function[17](#jah32954-bib-0017){ref-type="ref"}, [19](#jah32954-bib-0019){ref-type="ref"} after stroke. In addition, Sasaki and colleagues[14](#jah32954-bib-0014){ref-type="ref"} reported that high‐frequency transcranial magnetic stimulation over the cortical motor areas that represent both legs led to significantly greater improvement in the Brunnstrom Recovery Stage score than sham stimulation in subjects with acute stroke.

The mechanisms that mediate the effects of bilateral intervention in subjects with stroke include rebalancing interhemispheric inhibition,[20](#jah32954-bib-0020){ref-type="ref"}, [21](#jah32954-bib-0021){ref-type="ref"}, [22](#jah32954-bib-0022){ref-type="ref"} activating the homologous neural networks in both hemispheres,[23](#jah32954-bib-0023){ref-type="ref"}, [24](#jah32954-bib-0024){ref-type="ref"} and recruiting the neural networks of the contralesional hemisphere.[17](#jah32954-bib-0017){ref-type="ref"}, [23](#jah32954-bib-0023){ref-type="ref"}, [25](#jah32954-bib-0025){ref-type="ref"} The use of transcranial magnetic stimulation in subjects with stroke, in which the maximum voluntary contraction of the nonparetic hand was combined with less‐forceful contraction of the paretic hand, increased the cortical excitability of the ipsilesional motor representation area of the hand when compared with contraction of the paretic hand alone.[24](#jah32954-bib-0024){ref-type="ref"} Grefkes and colleagues[23](#jah32954-bib-0023){ref-type="ref"} used functional magnetic resonance imaging and dynamic causal modeling to demonstrate positive neural coupling between the ipsilesional primary motor cortex (M1) and the contralesional motor‐related areas in bilateral synchronized hand movements in subjects with stroke.[23](#jah32954-bib-0023){ref-type="ref"} Similarly, Luft and colleagues[25](#jah32954-bib-0025){ref-type="ref"} reported that activation of the contralesional cerebrum and ipsilesional cerebellum had increased after 6 weeks of bilateral arm training, but not after dose‐matched training based on the neurodevelopmental principles that focused on the paretic upper limb in subjects with stroke. In the same study,[25](#jah32954-bib-0025){ref-type="ref"} after exclusion of subjects without cortical activation changes from the analyses, the group with bilateral arm training also demonstrated greater improvement in hand function than the group with dose‐matched exercises.

Clinical trials of the effects of bilateral lower‐limb motor training in subjects with stroke are sparse. Johannsen and colleagues[26](#jah32954-bib-0026){ref-type="ref"} reported that a 10‐session bilateral lower‐limb training program with rhythmic auditory cueing led to greater improvement in step length and in the accuracy of the paretic foot‐aiming task in subjects with chronic stroke when compared with a control group of patients who underwent upper‐limb training.[26](#jah32954-bib-0026){ref-type="ref"}

Current evidence shows that bilateral intervention recruits spare neural substrates to enhance motor recovery[17](#jah32954-bib-0017){ref-type="ref"}, [20](#jah32954-bib-0020){ref-type="ref"}, [21](#jah32954-bib-0021){ref-type="ref"}, [22](#jah32954-bib-0022){ref-type="ref"}, [23](#jah32954-bib-0023){ref-type="ref"}, [24](#jah32954-bib-0024){ref-type="ref"}, [25](#jah32954-bib-0025){ref-type="ref"}; we thus hypothesized that the application of TENS over both paretic and nonparetic legs (Bi‐TENS) might induce greater and earlier improvement in lower‐limb motor function than the use of Uni‐TENS in subjects with stroke. A literature search revealed that no study has compared the efficacy of Bi‐TENS+TOT and Uni‐TENS+TOT on motor recovery after stroke. Therefore, this study aimed to compare the efficacy of a Bi‐TENS+TOT program versus a Uni‐TENS+TOT program for improving lower‐limb muscle strength, balance performance, and functional mobility in subjects with chronic stroke.

Methods {#jah32954-sec-0010}
=======

The data, analytic methods, and study materials will be made available to other researchers for purposes of reproducing the results or replicating the procedure. The data that support the findings of this study are available from the corresponding author upon reasonable request.

Study Procedures {#jah32954-sec-0011}
----------------

The study protocol was prospectively registered with ClinicalTrials.gov (identifier: NCT02152813). The study was conducted in a Balance and Neural Control Laboratory, and the Ethics Committee of the administrative institution approved the protocol. All participants gave written consent before participation. The study was conducted in accordance with the Declaration of Helsinki for human experiments.

Participants {#jah32954-sec-0012}
------------

The sample size was estimated prospectively using G\*power v3.1.0 (Franz Faul, University of Kiel, Germany) with an α level of 0.05 and power of 0.8. Because no previous study has compared the effects of bilateral electrical stimulation with those of unilateral stimulation on lower‐limb motor function in this population, the estimation is based on a recent systematic review and meta‐analysis[27](#jah32954-bib-0027){ref-type="ref"} that showed a medium to large effect size (Cohen\'s d=0.73) for bilateral movement training in the improvement of upper‐limb motor function after stroke. We selected a more conservative effect size of 0.6 in our model, so the total sample size was estimated to be 72 subjects (36 per group) to detect significant between‐groups differences. To allow for dropouts, we planned to recruit an additional 8 participants. Thus, the planned sample size was 80 (40 subjects per group).

Subjects with stroke were recruited from local self‐help groups via poster advertising. Subjects older than 85 years were excluded because old age frailty is commonly seen in this age group[28](#jah32954-bib-0028){ref-type="ref"} and may have a strong influence on motor recovery after stroke.[29](#jah32954-bib-0029){ref-type="ref"} Subjects were eligible to participate if they (1) were between 55 and 85 years of age; (2) had received a diagnosis of ischemic or hemorrhagic stroke by magnetic resonance imaging or computed tomographic scan \>1 year and \<10 years earlier; (3) were able to walk 3 m independently; (4) were able to score \>6 out of 10 on the Abbreviated Mental Test[30](#jah32954-bib-0030){ref-type="ref"}; (5) were able to follow instructions and give informed consent; and (6) had no skin allergy that would prevent the application of the TENS equipment. Subjects were excluded if they (1) had any additional medical, cardiovascular, or orthopedic condition that hindered training or assessment; (2) had a cardiac pacemaker; (3) had significant lower‐limb peripheral neuropathy (eg, diabetic polyneuropathy); or (4) had participated in other drug studies or clinical trials.

The subjects were stratified and randomly allocated into either a Bi‐TENS group or a Uni‐TENS group using Minimize computer software.[31](#jah32954-bib-0031){ref-type="ref"} The stratification was based on age (55--70 or 71--85 years), sex, the type of stroke (ischemic or hemorrhagic), and the side of hemiplegia. The stratification procedure served to avoid an imbalance in the distribution of the major demographic characteristics between the 2 groups. Randomization was performed immediately after the collection of demographic data. These procedures were conducted by an independent research assistant who was not involved in the assessment or treatment of these patients.

Training Protocols {#jah32954-sec-0013}
------------------

The training program comprised 20 sessions of TENS or placebo TENS with simultaneous TOT twice per week for 60 minutes per session.

TENS Protocol {#jah32954-sec-0014}
-------------

The 120Z Dual‐Channel TENS Unit (EMSphysio Ltd, Wantage, UK) was used to stimulate the nerve trunk of the common peroneal nerve. The stimulation frequency was set at 100 Hz, with a pulse width of 0.2 ms. The stimulation intensity was set at double the sensory threshold and below the motor threshold, which was confirmed by the absence of muscle twitching. The sensory threshold was defined as the minimum intensity that provoked a tingling sensation.[5](#jah32954-bib-0005){ref-type="ref"} Sensory stimulation was used in this study because it could enhance the neuronal activity and/or cortical excitability of the motor cortex via the corticocortical connections between S1 and M1.[32](#jah32954-bib-0032){ref-type="ref"}, [33](#jah32954-bib-0033){ref-type="ref"} In addition, the cutaneous sensory stimulation was applied simultaneously with the TOT, which comprised a series of functional tasks. Electrical stimulation that was above the motor threshold induced muscle twitching; this uncontrolled muscle twitching would produce conflicting afferent inputs during the performance of TOT.

For the placement of electrodes, the cathode electrode (ITO Co. Ltd, Tokyo, Japan: rubber electrodes \[40×41 mm\] and gel pad \[40×41 mm\]) was placed on the popliteal fossa, while the anode electrode was placed on the neck of the fibula. For the Bi‐TENS group, electrical stimulation was applied over the popliteal fossae of both legs. For the Uni‐TENS group, electrical stimulation was only applied to the paretic leg. Placebo TENS was applied to the nonparetic leg with an identical‐looking TENS device with the electrical circuit disconnected.

TOT Protocol {#jah32954-sec-0015}
------------

During the application of TENS, all subjects performed 60 minutes of TOT under the supervision of a registered physical therapist. The TOT program was adopted from a previous study.[5](#jah32954-bib-0005){ref-type="ref"} The TOT exercises included (1) stepping up and down to strengthen the muscles of both legs and to improve control in shifting the center of gravity; (2) heel‐raising exercises on an inclined wedge to strengthen both ankle plantarflexors; (3) assuming a semi‐squatting position to improve lower‐limb muscle endurance and proprioception in the knees and ankles; (4) standing on a dura disk to improve dynamic standing balance; (5) walking across obstacles to enhance anticipatory postural control; and (6) standing up from a chair, walking a short distance, and returning to the chair to promote a smooth transition between sitting, standing, and walking. Each exercise item lasted 10 minutes, so the total exercise time for each training session was 60 minutes. Guidelines for standardized exercise progression[5](#jah32954-bib-0005){ref-type="ref"} were implemented to standardize the exercise intensity.

Outcome Measures {#jah32954-sec-0016}
----------------

The subjects were assessed by a trained research assistant who was blinded to group allocation. The assessments were performed at baseline (A0); after 10 sessions (5 weeks; midtraining; A1); after 20 sessions (10 weeks; after training; A2); and 3 months after the cessation of training (follow‐up; A3). For all physical assessments, 1 practice trial was given, and the average of 3 test trials was used for data analysis. The muscle strength of paretic ankle dorsiflexors (pDF) and plantarflexors (pPF) and paretic knee extensors (pKE) and flexors (pKF) were selected as the primary outcome measures of this study. The ankle and knee muscle strength of the nonparetic ankle dorsiflexors and plantarflexors and the nonparetic knee extensors and flexors (npKF), along with the results of the Step Test and the Lower Extremity Motor Coordination Test, were the secondary outcome measures. The Berg Balance Scale and the Timed Up and Go test were assessed to further capture the effects of the interventions on the subjects\' functional mobility. These 2 outcome measures were not prespecified in the clinical trial registration.

Maximum Isometric Voluntary Contraction of Ankle Muscles {#jah32954-sec-0017}
--------------------------------------------------------

The maximum isometric voluntary contraction of the bilateral ankle dorsiflexors and plantarflexors were measured with a Nicholas handheld dynamometer (model 01,160; Lafayette Instrument Company, Lafayette, IN). The ankle muscle strength was assessed with a standardized position and placement of the dynamometer.[34](#jah32954-bib-0034){ref-type="ref"} Good to excellent reliability (intraclass correlation coefficient \[ICC\], 0.84--0.99) has been reported for the use of a handheld dynamometer to assess leg muscle strength in subjects with chronic stroke.[35](#jah32954-bib-0035){ref-type="ref"}

Isokinetic Peak Torque {#jah32954-sec-0018}
----------------------

The strength of bilateral knee extension and flexion was measured with a Cybex 6000 Dynamometer (Lumex, Inc, Ronkonkoma, NY). Knee muscle strength was measured with an isokinetic dynamometer instead of a handheld dynamometer as specified in the clinical trial registration because the subjects of this study demonstrated good knee muscle strength, which made the measurement with a handheld dynamometer less accurate.[36](#jah32954-bib-0036){ref-type="ref"} The peak concentric isokinetic torques of knee flexion and extension at 90°/s were measured with subjects in a sitting position. The excellent test--retest reliability (ICC, 0.94) of the use of a Cybex 6000 Dynamometer to measure peak isokinetic torques in subjects with chronic stroke was reported in a previous study.[37](#jah32954-bib-0037){ref-type="ref"}

Lower Extremity Motor Coordination Test {#jah32954-sec-0019}
---------------------------------------

The Lower Extremity Motor Coordination Test (LEMOCOT) was used to measure the intralimb coordination of both legs.[38](#jah32954-bib-0038){ref-type="ref"} Good test--retest reliability of the LEMOCOT (ICC, 0.83--0.88) has been reported for the assessment of subjects with stroke.[38](#jah32954-bib-0038){ref-type="ref"} Two flat, circular targets were secured on the floor 30 cm apart in an anteroposterior direction. The participants were seated with their hips and knees in 90° of flexion and were instructed to touch the 2 targets alternately with their big toe for 20 s. The total number of repetitions was counted.

Step Test {#jah32954-sec-0020}
---------

The Step Test (ST) was used to assess dynamic standing balance[39](#jah32954-bib-0039){ref-type="ref"} by recording the number of times the subject could place 1 foot on a 7.5‐cm step and back to the ground within 15 s. The ST scores have shown excellent intrarater and interrater reliability in subjects with chronic stroke (ICC, 0.98--0.99).[39](#jah32954-bib-0039){ref-type="ref"} The number of repetitions with the paretic and nonparetic legs was recorded.

Berg Balance Scale {#jah32954-sec-0021}
------------------

The BBS was used to measure functional balance performance.[40](#jah32954-bib-0040){ref-type="ref"} The scale consists of 14 items in which a subject\'s ability to maintain stability during a specified functional task is rated on a 5‐point scale (0--4). The maximum score is 56, and a higher score indicates better balance performance. The BBS has shown excellent test--retest reliability (ICC, 0.95)[40](#jah32954-bib-0040){ref-type="ref"} in the assessment of subjects with stroke. To dampen the ceiling effect, a standardized assessment procedure was implemented to challenge the paretic leg\'s weight‐bearing ability.[41](#jah32954-bib-0041){ref-type="ref"}

Timed Up and Go Test {#jah32954-sec-0022}
--------------------

The Timed Up and Go (TUG) test was used to assess functional mobility.[42](#jah32954-bib-0042){ref-type="ref"} All subjects were asked to stand up from a chair, walk forward for 3 m, turn 180°, walk back to the chair, and sit down. The TUG has demonstrated excellent test--retest reliability in the assessment of subjects with stroke (ICC, 0.95).[42](#jah32954-bib-0042){ref-type="ref"}

Statistical Analysis {#jah32954-sec-0023}
--------------------

Intention‐to‐treat analysis was adopted, and SPSS (v23.0; IBM, Armonk, NY) was used for all statistical analyses. A *P* value of 0.05 or lower was considered to indicate statistical significance.

The demographic characteristics and outcome measures were summarized with descriptive statistics. The baseline characteristics of the 2 groups were compared with a χ^2^ test, independent *t* test, or Mann--Whitney *U* test, as appropriate. A linear mixed model (LMM) was used to compare the differential changes in the outcomes between the 2 groups over time because it accounts well for intracorrelated repeated‐measures data.[43](#jah32954-bib-0043){ref-type="ref"} The groups, time points, and group‐by‐time interaction were included as fixed effects. The random intercept and random slope of change in the outcome variables over time were included as random effects. Maximum likelihood was chosen as the estimation method, and the heterogeneous first‐order autoregressive covariance structure was selected to estimate the model parameters. The group‐by‐time interaction term of the LLM is the focus of interest in the current study. Bonferroni correction was applied to adjust the *P* value of the interaction term of primary outcomes and the *P* value of post hoc analyses, in order to prevent inflation of the type 1 error rate. The confidence intervals of the regression coefficients of the interaction terms were also adjusted accordingly.[44](#jah32954-bib-0044){ref-type="ref"}

A significant group‐by‐time interaction effect indicated that the variables changed at different rates in the 2 groups. Where the group‐by‐time interaction effect was significant, the between‐groups and within‐group differences were evaluated by dividing the data into 3 time points and 2 groups, respectively. The LMM was then repeated with the interaction effect, and either the time or the group effect was removed and followed by post hoc analysis. In the absence of a significant group‐by‐time interaction, a significant time effect indicated that the variables changed significantly with a similar trend in both groups. Post hoc analysis was conducted to determine at which time point the outcome variable had changed significantly from the baseline. The carryover effects were analyzed by comparing the results between A2 and A3 with the same model specifications mentioned above. For the analyses of between‐groups differences and a carryover effect, the last observation carried forward method was used to handle missing data. The last observation carried forward method was chosen as it is a more conservative method to impute data with dropout in this study. A previous study suggested that the use of last observation carried forward method can introduce bias, especially when progressive diseases were studied or when adverse effects could be introduced by the intervention.[45](#jah32954-bib-0045){ref-type="ref"} In the current study, all subjects were already in their chronic static phase of stroke, in which spontaneous improvement or rapid deterioration in physical functions should be unlikely to occur. In addition, none of the dropout cases reported any adverse effect resulted from the training; thus it is unlikely that the last observation carried forward method would overestimate the outcomes.

Results {#jah32954-sec-0024}
=======

One hundred two subjects with chronic stroke were screened between February 2014 and April 2016. Eighty fulfilled the inclusion criteria for recruitment into this study. Their mean age was 62.0 years, and the mean time since the stroke was 5.2 years. Their mean walking speed was 0.77 ms^−1^, which indicated limited ambulatory ability[46](#jah32954-bib-0046){ref-type="ref"} (Table [1](#jah32954-tbl-0001){ref-type="table-wrap"}). No significant differences existed between the 2 groups at baseline (Table [1](#jah32954-tbl-0001){ref-type="table-wrap"}). Six subjects (3 in each group) did not complete the training program. Another 5 (2 in the Bi‐TENS group and 3 in the Uni‐TENS group) were lost to follow‐up ([Figure](#jah32954-fig-0001){ref-type="fig"}).

###### 

Demographic Characteristics and Results of Baseline Assessment of Subjects With Stroke Shown by Group

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                  Total Sample (n=80)                    Bi‐TENS (n=40)                    Uni‐TENS (n=40)                Between‐Groups Comparison
  --------------------------------------------------------------- -------------------------------------- --------------------------------- ------------------------------ ---------------------------
  Sex (male/female)                                               50 (62.5)/30 (47.5)                    26 (65)/14 (35)                   24 (60)/16 (40)                0.21; 0.821

  Side of hemiplegia (right/left)                                 46 (57.5)/34 (42.5)                    24 (60)/16 (40)                   22 (55)/18 (45)                0.21; 0.651

  Type of stroke (ischemic/hemorrhagic/mixed)                     49 (61.3)/30 (37.5)/1 (1.3)            22 (55)/17 (42.5)/1 (2.5)         27 (67.5)/13 (32.5)/0 (0.0)    2.04; 0.360

  Living with caregiver (yes/no)                                  70 (87.5)/10 (12.5)                    35 (87.5)/5 (12.5)                35 (87.5)/5 (12.5)             0.00; 1.000

  Employed/working (yes/no)                                       6 (7.5)/74 (92.5)                      4 (10)/36 (90)                    4 (10)/36 (90)                 0.00; 1.000

  Education level (primary or below/secondary/college or above)   25 (31.3)/44 (55.0)/11 (13.8)          13 (32.5)/21 (52.5)/6 (15)        12 (30.0)/23 (57.5)/5 (12.5)   0.22; 0.895

  Using walking aid (yes/no)                                      53 (66.2)/27 (33.8)                    25 (62.5)/15 (47.5)               28 (70)/12 (30)                0.50; 0.478

                                                                  Mean±SD (ranges)                       Independent *t* test*; P* value                                  

  Age, y                                                          62.0±5.4 (55.0--73.1)                  61.8±5.7 (55.0--73.1)             62.2±5.1 (55.0--72.1)          −0.37; 0.715

  Body mass index, kg·m^−2^                                       24.2±3.1 (18.0--32.2)                  24.6±3.4 (18.0--32.2)             23.8±2.8 (18.0--30.0)          −0.77; 0.443

  Time since stroke, y                                            5.2±3.1 (1.0--10)                      5.2±3.1 (1.0--10.0)               5.7±2.8 (1.0--10)              1.14; 0.256

  Paretic ankle dorsiflexion strength, kg                         7.6±5.2 (0.0--23.7)                    7.9±4.9 (0.0--18.5)               7.3±5.6 (0.0--23.7)            0.50; 0.616

  Nonparetic ankle dorsiflexion strength, kg                      15.3±3.6 (2.7--25.8)                   15.6±3.6 (7.4--23.9)              15.0±3.7 (2.7--25.8)           0.74; 0.460

  Paretic ankle plantarflexion strength, kg                       12.2±5.5 (0.0--28.4)                   12.6±5.7 (0.0--25.7)              11.9±5.4 (2.3--28.4)           0.74; 0.460

  Nonparetic ankle plantarflexion strength, kg                    17.8±3.7 (11.7--35.4)                  18.5±4.4 (11.6--35.4)             17.1±2.9 (11.2--24.8)          1.70; 0.094

  Paretic knee extension peak torque, Nm                          20.8±14.4 (4.0--70.0)                  20.8±13.1 (4.0--54.0)             20.7±12.4 (6.0--70.0)          0.35; 0.972

  Nonparetic knee extension peak torque, Nm                       43.5±18.1 (11.0--110.0)                44.9±20.6 (11.0--94.0)            41.4±12.6 (16.0--80.0)         0.68; 0.498

  Paretic knee flexion peak torque, Nm                            7.6±6.3 (0.0--26.0)                    8.5±6.7 (0.0--26.0)               6.8±5.9 (1.0--26.0)            1.19; 0.239

  Nonparetic knee flexion peak torque, Nm                         20.3±8.8 (7.0--56.0)                   21.9±9.8 (8.0--56.0)              18.6±7.4 (7.0--38.0)           1.74; 0.086

  Lower Extremity Motor Coordination Test; paretic side           11.9±10.4 (0.0--40.0)                  12.9±12.4 (0.0--40.0)             10.8±7.7 (0.0--28.0)           0.94; 0.363

  Lower Extremity Motor Coordination Test; nonparetic side        34.9±9.4 (18.5--76.0)                  36.1±11.2 (18.5--76.0)            33.8±7.3 (18.5--53.0)          1.07; 0.290

  10‐m Walk Test, ms^−1^                                          0.77±0.31 (0.22--1.89)                 0.79±0.34 (0.22--1.89)            0.75±0.29 (0.29--1.89)         0.61; 0.543

  Step test; paretic side                                         7.4±3.5 (0.0--16.7)                    7.5±3.7 (0.0--15.0)               7.3±3.4 (0.0--16.7)            0.31; 0.761

  Step test; nonparetic side                                      9.2±3.8 (0.0--27.3)                    9.1±3.6 (0.0--14.3)               9.2±4.0 (0.0--27.3)            −0.02; 0.981

  TUG, s                                                          19.2±8.1 (4.4--43.3)                   19.2±8.3 (4.4--40.9)              19.2±8.0 (8.9--43.3)           −0.01; 0.992

                                                                  Median±25th/75th Percentile (Ranges)   Mann--Whitney *U* test\                                          
                                                                                                         Z; *P* value                                                     

  Abbreviated Mental Test                                         10±9/10 (3)                            10±9/10 (3)                       10±9/10 (2)                    −1.34; 0.180

  BBS                                                             49±46/51 (21)                          49±45/51 (21)                     49±46/51 (21)                  −0.12; 0.908
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

BBS indicates Berg Balance Scale; Bi‐TENS, bilateral transcutaneous electrical stimulation; TUG, Timed Up and Go Test; Uni‐TENS, unilateral transcutaneous electrical stimulation.

![Consolidated Standards of Reporting Trials (CONSORT) flow diagram of the study. Bi‐TENS indicates bilateral transcutaneous electrical nerve stimulation; Uni‐TENS, unilateral transcutaneous electrical nerve stimulation.](JAH3-7-e007341-g001){#jah32954-fig-0001}

For the primary outcomes, the LMM showed that the group‐by‐time interaction effects were significant only for the pDF strength (β=1.32; *P*=0.032). The results suggest that for every 10 sessions of training, the Bi‐TENS group demonstrated an additional 1.32‐kg increase in pDF strength. Post hoc analyses revealed that the Bi‐TENS group had greater improvement than the Uni‐TENS group in the pDF strength at A1 (mean difference, 2.62; *P*=0.036) and at A2 (mean difference, 3.23; *P*=0.034). When compared with baseline, the Bi‐TENS group showed improvement in the pDF strength at A1 (mean difference, 2.67; *P*\<0.001) and at A2 (mean difference, 4.46; *P*\<0.001). However, the Uni‐TENS group showed improvement in the pDF strength (mean difference, 1.81; *P*=0.005). Results of LMM showed that none of the group effect was significant. The time effects were significant for pDF strength, pPF strength, pKE peak torque, and pKF peak torque (*P*≤0.05; Table [2](#jah32954-tbl-0002){ref-type="table-wrap"}). Post hoc analyses of the significant time effects showed that improvement in the pKE peak torque (mean difference, 6.01; *P*\<0.001) and pKF peak torque (mean difference, 5.16; *P*\<0.001) began at A1, but improvement in the pPF strength (mean difference, 2.63; *P*\<0.001) was demonstrated in A2 only.

###### 

Results of Linear Mixed Models for Subjects in the Bi‐TENS Group Compared With Those in the Uni‐TENS Group From A0 to A2

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                 Bi‐TENS     Uni‐TENS    Fixed Effects                                                       
  ---------------------------------------------- ----------- ----------- ------------------------------------------------ ------------------ -----------------------------------------------
  Paretic ankle dorsiflexion strength, kg                                                                                                    

   Wk 0                                          7.9±4.9     7.3±5.6     0.90;\                                           −0.50;\            1.32;\
                                                                         0.22 to 1.59;\                                   −2.86 to 1.86;\    0.08 to 2.56;\
                                                                         0.010[a](#jah32954-note-0003){ref-type="fn"}     0.675              0.032 [a](#jah32954-note-0003){ref-type="fn"}

   Wk 5                                          10.6±5.4    8.0±5.5                                                                         

   Wk 10                                         12.4±6.5    9.2±6.9                                                                         

  Nonparetic ankle dorsiflexion strength, kg                                                                                                 

   Wk 0                                          15.6±3.6    15.0±3.7    2.05;\                                           1.21;\             −0.14;\
                                                                         1.33 to 2.78;\                                   −0.87 to 3.29;\    −1.16 to 0.89;\
                                                                         \<0.001[b](#jah32954-note-0004){ref-type="fn"}   0.249              0.790

   Wk 5                                          18.7±3.8    16.9±3.7                                                                        

   Wk 10                                         19.4±5.0    19.1±4.3                                                                        

  Paretic ankle plantarflexion strength, kg                                                                                                  

   Wk 0                                          12.6±5.7    11.9±5.4    0.99;\                                           0.44;\             0.65;\
                                                                         0.11 to 1.88;\                                   −2.48 to 3.36;\    −0.97 to 2.26;\
                                                                         0.029[a](#jah32954-note-0003){ref-type="fn"}     0.766              1.00

   Wk 5                                          14.5±6.2    11.9±5.6                                                                        

   Wk 10                                         15.9±7.3    13.9±6.8                                                                        

  Nonparetic ankle plantarflexion strength, kg                                                                                               

   Wk 0                                          18.5±4.4    17.1±2.9    1.65;\                                           1.40;\             0.085;\
                                                                         0.68 to 2.64;\                                   −0.96 to 3.77;\    −1.30 to 1.47;\
                                                                         0.001                                            0.241              0.903

   Wk 5                                          19.9±4.0    18.1±4.2                                                                        

   Wk 10                                         22.0±6.2    20.4±6.4                                                                        

  Paretic knee extension peak torque, Nm                                                                                                     

   Wk 0                                          20.8±13.1   20.7±12.4   2.20\                                            −0.46\             1.48\
                                                                         0.34 to 4.06;\                                   −7.57 to 6.65;\    −1.89 to 4.84;\
                                                                         0.021[a](#jah32954-note-0003){ref-type="fn"}     0.898              1.00

   Wk 5                                          28.9±19.1   24.6±14.3                                                                       

   Wk 10                                         28.2±15.4   25.1±15.8                                                                       

  Nonparetic knee extension peak torque, Nm                                                                                                  

   Wk 0                                          44.9±20.6   41.4±12.6   1.98;\                                           4.35;\             −0.74;\
                                                                         −0.54 to 4.49;\                                  −5.19 to 13.89;\   −4.29 to 2.81;\
                                                                         0.122                                            0.371              0.682

   Wk 5                                          46.6±20.8   43.6±17.1                                                                       

   Wk 10                                         47.4±19.6   45.4±13.1                                                                       

  Paretic knee flexion peak torque, Nm                                                                                                       

   Wk 0                                          8.5±6.7     6.8±5.9     2.69;\                                           1.48;\             0.89;\
                                                                         1.33 to 4.04;\                                   −2.19 to 5.16;\    −1.58 to 3.36;\
                                                                         ≤0.001[b](#jah32954-note-0004){ref-type="fn"}    0.426              1.000

   Wk 5                                          15.1±13.7   10.5±7.5                                                                        

   Wk 10                                         15.6±12.6   12.2±8.2                                                                        

  Nonparetic knee flexion peak torque, Nm                                                                                                    

   Wk 0                                          21.9±9.8    18.6±7.4    2.86;\                                           1.94;\             0.16;\
                                                                         1.38 to 4.34;\                                   −2.94 to 6.82;\    −1.93 to 2.26;\
                                                                         ≤0.001[b](#jah32954-note-0004){ref-type="fn"}    0.431              0.878

   Wk 5                                          23.8±10.9   24.1±9.3                                                                        

   Wk 10                                         28.0±12.7   24.3±7.5                                                                        

  LEMOCOT; paretic side                                                                                                                      

   Wk 0                                          12.9±12.4   10.8±7.7    2.08;\                                           1.90;\             −0.04;\
                                                                         0.99 to 3.17;\                                   −2.47 to 6.28;\    −1.59 to 1.50;\
                                                                         ≤0.001[b](#jah32954-note-0004){ref-type="fn"}    0.389              0.955

   Wk 5                                          14.8±13.7   13.5±9.9                                                                        

   Wk 10                                         17.0±15.1   15.0±12.2                                                                       

  LEMOCOT; nonparetic side                                                                                                                   

   Wk 0                                          36.1±11.2   33.8±7.3    3.56;\                                           2.26;\             −0.28;\
                                                                         2.24 to 7.35;\                                   −2.83 to 7.35;\    −2.14 to 1.58;\
                                                                         ≤0.001[b](#jah32954-note-0004){ref-type="fn"}    0.379              0.763

   Wk 5                                          38.8±10.8   37.6±8.5                                                                        

   Wk 10                                         42.6±10.3   40.9±9.3                                                                        

  Step test; paretic side                                                                                                                    

   Wk 0                                          7.5±3.7     7.3±3.4     0.96;\                                           0.34;\             0.02;\
                                                                         0.43 to 1.50;\                                   −1.52 to 2.21;\    −0.74 to 0.78;\
                                                                         0.001[a](#jah32954-note-0003){ref-type="fn"}     0.716              0.954

   Wk 5                                          8.6±3.7     8.0±2.7                                                                         

   Wk 10                                         9.5±4.1     9.2±4.2                                                                         

  Step test; nonparetic side                                                                                                                 

   Wk 0                                          9.1±3.6     9.2±4.0     0.87;\                                           0.07;\             0.17;\
                                                                         0.15 to 1.60;\                                   −2.16 to 2.29;\    −0.85 to 1.2;\
                                                                         0.019[a](#jah32954-note-0003){ref-type="fn"}     0.954              0.745

   Wk 5                                          10.5±3.7    9.6±2.9                                                                         

   Wk 10                                         11.2±4.3    10.9±4.9                                                                        

  BBS                                                                                                                                        

   Wk 0                                          48.2±4.5    48.4±4.1    1.23;\                                           0.08;\             −0.18;\
                                                                         0.69 to 1.78;\                                   −2.25 to 2.4;\     −0.94 to 0.59;\
                                                                         ≤0.001[b](#jah32954-note-0004){ref-type="fn"}    0.950              0.652

   Wk 5                                          49.8±3.6    49.9±3.9                                                                        

   Wk 10                                         50.4±3.6    50.9±3.3                                                                        

  TUG, s                                                                                                                                     

   Wk 0                                          19.2±8.3    19.2±8.0    −0.82;\                                          1.49;\             −1.54;\
                                                                         −1.54 to −0.10;\                                 −1.32 to 4.30;\    −2.55 to −0.52;\
                                                                         0.026[a](#jah32954-note-0003){ref-type="fn"}     0.485              0.004[a](#jah32954-note-0003){ref-type="fn"}

   Wk 5                                          17.2±7.6    18.8±8.0                                                                        

   Wk 10                                         14.5±6.4    17.5±7.3                                                                        
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The CIs of interaction term of the primary outcomes were adjusted with Bonferroni correction; thus, 98.75% CIs were reported for the coefficient of interaction term of primary outcomes. 95% CIs were reported for rest of the coefficients. BBS indicates Berg Balance Scale; Bi‐TENS, bilateral transcutaneous electrical stimulation; CI, confidence interval; LEMOCOT, Lower Extremity Motor Coordination Test; TUG, Timed Up and Go Test; Uni‐TENS, unilateral transcutaneous electrical stimulation.

*P≤*0.05.

*P≤*0.001.

For the secondary outcomes, the LMM showed that none of the group effects were significant. The time effects were significant for all secondary outcomes except the nonparetic knee extensors peak torque (*P*≤0.05; Table [2](#jah32954-tbl-0002){ref-type="table-wrap"}). The group‐by‐time interaction effects were significant only for the TUG completion times (β=−1.54; *P*=0.004). The results suggest that for every 10 sessions of training, the Bi‐TENS group demonstrated a further reduction of 1.54 s in the TUG completion time when compared with the Uni‐TENS group.

Post hoc analyses of the significant interaction effect reveal that the Bi‐TENS group had greater improvement than the Uni‐TENS group in the TUG completion time at A2 (mean difference, −3.09; *P*=0.047). When compared with baseline, the Bi‐TENS group showed improvement in the TUG completion time at A1 (mean difference, −2.01; *P*=0.001) and at A2 (mean difference, −3.76; *P*\<0.001). However, the Uni‐TENS group showed improvement in the TUG completion time (mean difference, −1.64; *P*=0.01) only at A2.

Post hoc analyses of the significant time effects showed that improvements in the nonparetic ankle dorsiflexors (mean difference, 2.48; *P*\<0.001), nonparetic knee flexors peak torque (mean difference, 3.65; *P*\<0.001), paretic LEMOCOT score (mean difference, 2.31; *P*=0.001), nonparetic LEMOCOT score (mean difference, 3.26; *P*=0.001), paretic ST score (mean difference, 9.27; *P*=0.009), nonparetic ST score (mean difference, 0.88; *P*=0.021), and BBS score (mean difference, 1.50; *P*\<0.001) all began at A1. Improvement in nonparetic ankle plantarflexors strength (mean difference; 3.40; *P*\<0.001) was demonstrated only at A2. In the analyses of carryover effects, none of the group‐by‐time interaction effects was significant. The time effects were significant for pPF (β=−1.75; *P*=0.021; Table [3](#jah32954-tbl-0003){ref-type="table-wrap"}).

###### 

Results of Linear Mixed Models for Subjects in the Bi‐TENS Group Compared With Those in the Uni‐TENS Group From A2 to A3

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                 Bi‐TENS     Uni‐TENS    Fixed Effects                                                                                 
  ---------------------------------------------- ----------- ----------- ---------------------------------------------- ---------------------------------------------- -----------------
  Paretic ankle dorsiflexion strength, kg                                                                                                                              

   Wk 10                                         12.4±6.5    9.2±6.9     −0.82;\                                        4.19;\                                         −0.95;\
                                                                         −2.01 to 0.38;\                                0.21 to 8.16;\                                 −3.11 to 1.21;\
                                                                         0.177                                          0.039[a](#jah32954-note-0006){ref-type="fn"}   1.00

   3‐mo follow‐up                                10.6±5.7    8.3±6.5                                                                                                   

                                                                                                                                                                       

  Nonparetic ankle dorsiflexion strength, kg                                                                                                                           

   Wk 10                                         19.4±5.0    19.1±4.3    −0.86;\                                        0.74;\                                         −0.41;\
                                                                         −1.97 to 0.25;\                                −2.37 to 3.85\                                 −1.98 to 1.16;\
                                                                         0.126                                          0.637                                          0.604

   3‐mo follow‐up                                18.2±4.7    18.3±4.2                                                                                                  

                                                                                                                                                                       

  Paretic ankle plantarflexion strength, kg                                                                                                                            

   Wk 10                                         15.9±7.3    13.9±6.8    −1.75;\                                        2.57;\                                         −0.58;\
                                                                         −3.21 to 0.29;\                                −1.91 to 7.04;\                                −3.23 to 2.08;\
                                                                         0.020[a](#jah32954-note-0006){ref-type="fn"}   0.258                                          1.00

   3‐mo follow‐up                                13.5±6.2    12.1±6.3                                                                                                  

                                                                                                                                                                       

  Nonparetic ankle plantarflexion strength, kg                                                                                                                         

   Wk 10                                         22.0±6.2    20.4±6.4    −1.31;\                                        2.25;\                                         −0.67;\
                                                                         −2.68 to 0.07;\                                −1.97 to 6.47;\                                −2.61 to 1.27;\
                                                                         0.062                                          0.292                                          0.494

   3‐mo follow‐up                                20.0±4.4    19.1±5.6                                                                                                  

                                                                                                                                                                       

  Paretic knee extension peak torque, Nm                                                                                                                               

   Wk 10                                         28.2±15.4   25.1±15.8   0.33;\                                         3.00;\                                         0.05;\
                                                                         −2.51 to 3.17;\                                −5.80 to 11.80;\                               −5.12 to 5.22;\
                                                                         0.821                                          0.499                                          1.00

   3‐mo follow‐up                                28.5±16.9   25.4±14.8                                                                                                 

                                                                                                                                                                       

  Nonparetic knee extension peak torque, Nm                                                                                                                            

   Wk 10                                         47.4±19.6   45.4±13.1   2.58;\                                         2.20;\                                         −0.15;\
                                                                         −2.15 to 7.30;\                                −9.33 to 13.73;\                               −6.83 to 6.54;\
                                                                         0.281                                          0.705                                          0.964

   3‐mo follow‐up                                49.8±19.2   47.9±17.1                                                                                                 

                                                                                                                                                                       

  Paretic knee flexion peak torque, Nm                                                                                                                                 

   Wk 10                                         15.6±12.6   12.2±8.2    0.30;\                                         7.20;\                                         −3.75;\
                                                                         −1.93 to 2.53;\                                −0.44 to 13.96;\                               −7.79 to 0.30\
                                                                         0.790                                          0.037[a](#jah32954-note-0006){ref-type="fn"}   0.080

   3‐mo follow‐up                                12.2±9.2    12.5±6.3                                                                                                  

                                                                                                                                                                       

  Nonparetic knee flexion peak torque, Nm                                                                                                                              

   Wk 10                                         28.0±12.7   24.3±7.5    0.75;\                                         6.95;\                                         −3.25;\
                                                                         −2.54 to 2.69;\                                −0.36 to 14.26;\                               −6.96 to 0.46;\
                                                                         0.955                                          0.062                                          0.085

   3‐mo follow‐up                                24.8±7.9    24.4±10.3                                                                                                 

                                                                                                                                                                       

  LEMOCOT; paretic side                                                                                                                                                

   Wk 10                                         17.0±15.1   15.0±12.2   −0.22;\                                        1.38;\                                         0.64;\
                                                                         −2.75 to 2.31;\                                −6.24 to 9.00;\                                −2.93 to 4.22;\
                                                                         0.863                                          0.735                                          0.725

   3‐mo follow‐up                                17.3±16.7   14.7±11.8                                                                                                 

                                                                                                                                                                       

  LEMOCOT; nonparetic side                                                                                                                                             

   Wk 10                                         42.6±10.3   40.9±9.3    −1.50;\                                        3.91;\                                         −2.23;\
                                                                         −4.01 to 1.02;\                                −2.58 to 10.41;\                               −5.79 to 1.33;\
                                                                         0.240                                          0.234                                          0.216

   3‐mo follow‐up                                38.9±11.8   39.4±8.4                                                                                                  

                                                                                                                                                                       

  Step test; paretic side                                                                                                                                              

   Wk 10                                         9.5±4.1     9.2±4.2     −0.32;\                                        0.38;\                                         −0.09;\
                                                                         −0.97 to 0.34;\                                −1.94 to 2.69;\                                −1.02 to 0.84;\
                                                                         0.342                                          0.747                                          0.850

   3‐mo follow‐up                                9.1±4.2     8.9±3.6                                                                                                   

                                                                                                                                                                       

  Step test; nonparetic side                                                                                                                                           

   Wk 10                                         11.2±4.3    10.9±4.9    −0.52;\                                        0.18;\                                         0.14;\
                                                                         −1.66 to 0.61;\                                −3.11 to 3.46;\                                −1.46 to 1.75;\
                                                                         0.363                                          0.916                                          0.858

   3‐mo follow‐up                                10.8±4.3    10.4±3.0                                                                                                  

                                                                                                                                                                       

  BBS                                                                                                                                                                  

   Wk 10                                         50.4±3.6    50.9±3.3    −0.13;\                                        −0.80;\                                        0.28;\
                                                                         −0.82 to 0.57;\                                −2.87 to 1.27;\                                −0.70 to 1.25;\
                                                                         0.720                                          0.445                                          0.578

   3‐mo follow‐up                                50.5±3.5    50.8±3.4                                                                                                  

                                                                                                                                                                       

  TUG, s                                                                                                                                                               

   Wk 10                                         14.5±6.4    17.5±7.3    0.40;\                                         −3.80;\                                        0.71;\
                                                                         −0.81 to 1.61;\                                −7.31 to −0.28;\                               −1.04 to 2.40;\
                                                                         0.514                                          0.036[a](#jah32954-note-0006){ref-type="fn"}   0.431

   3‐mo follow‐up                                15.6±7.3    18.0±8.1                                                                                                  

                                                                                                                                                                       
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The CIs of interaction term of the primary outcomes were adjusted with Bonferroni correction; thus, 98.75% CIs were reported for the coefficient of interaction term of primary outcomes. 95% CI were reported for rest of the coefficients. Bi‐TENS indicates bilateral transcutaneous electrical stimulation; CI, confidence interval; Uni‐TENS, unilateral transcutaneous electrical stimulation.

*P≤*0.05.

Discussion {#jah32954-sec-0025}
==========

The results of this study demonstrate that Bi‐TENS+TOT induced greater and earlier improvement in the pDF strength and greater improvement in the TUG completion time than Uni‐TENS+TOT. Although there were no between‐groups difference of other outcome measures, both treatments demonstrated significant improvements in the nonparetic ankle dorsiflexors strength, pKE, pKF, and nonparetic knee flexors peak torque, paretic and nonparetic LEMOCOT scores, paretic and nonparetic ST scores, and BBS scores after 10 training sessions and significant improvements in pPF and nonparetic ankle plantarflexors strength after 20 training sessions. In general, the training effects on all outcome measures could be maintained 3 months after training had ended, except for the pPF strength.

Primary Outcomes {#jah32954-sec-0026}
----------------

To the best of our knowledge, this is the first study to compare the efficacy of Bi‐TENS+TOT and Uni‐TENS+TOT in the improvement of lower‐limb motor function after stroke. The notion of Bi‐TENS was inspired by the success of bilateral motor training,[15](#jah32954-bib-0015){ref-type="ref"}, [16](#jah32954-bib-0016){ref-type="ref"}, [17](#jah32954-bib-0017){ref-type="ref"}, [18](#jah32954-bib-0018){ref-type="ref"}, [19](#jah32954-bib-0019){ref-type="ref"} and positive findings[26](#jah32954-bib-0026){ref-type="ref"} have also been reported with bilateral leg training after stroke. In addition, training of the nonparetic limb has also been reported to enhance motor recovery in paretic limbs.[15](#jah32954-bib-0015){ref-type="ref"}, [47](#jah32954-bib-0047){ref-type="ref"}

Based on the findings of neuroanatomical[48](#jah32954-bib-0048){ref-type="ref"} and clinical[23](#jah32954-bib-0023){ref-type="ref"}, [24](#jah32954-bib-0024){ref-type="ref"} studies, the underlying mechanisms that mediate the effects of Bi‐TENS might include the enhancement of interhemispheric interaction, possibly via the corpus callosum, which is the white matter in the human brain that connects the 2 hemispheres via more than 200 million axonal connections.[48](#jah32954-bib-0048){ref-type="ref"} The motor areas of the 2 hemispheres have been shown with functional magnetic resonance imaging and diffusion tensor imaging to be connected via the posterior body of the corpus callosum.[48](#jah32954-bib-0048){ref-type="ref"} The results of clinical studies have demonstrated that bilateral pinch gripping could enhance ipsilesional M1 excitability when compared with unilateral pinch gripping with either hand in subjects with stroke,[24](#jah32954-bib-0024){ref-type="ref"} which was shown by an increase in the motor evoked potential amplitude recorded from the first dorsal interosseous of the paretic hand.[24](#jah32954-bib-0024){ref-type="ref"} Moreover, Grefkes and colleagues[23](#jah32954-bib-0023){ref-type="ref"} demonstrated in a sample of 11 subjects with subacute and subcortical stroke that bilateral hand movements resulted in facilitatory neural coupling between the M1 and supplementary motor areas of the 2 cerebral hemispheres. Simultaneous activation of bilateral sensorimotor cortices via TENS might exert a similar effect of enhancing the interhemispheric interaction in both hemispheres via the corpus callosum, thus enhancing the effects of motor training.

The neural networks of the contralesional hemisphere might contribute to the motor recovery of the paretic limb after repetitive application of TENS over both legs. Dragert and Zehr[47](#jah32954-bib-0047){ref-type="ref"} reported that high‐intensity ankle dorsiflexion resistance training on the nonparetic ankle resulted in a 34% increase in nonparetic ankle dorsiflexors strength and a 31% increase in pDF strength in 19 subjects with chronic stroke.[47](#jah32954-bib-0047){ref-type="ref"} It is plausible that the application of TENS over the nonparetic leg activated the contralesional hemisphere and enhanced the paretic ankle strength by recruiting the contralesional neural networks. The Bi‐TENS+TOT group showed earlier and greater improvement in pDF strength with as little as 10 sessions of training, probably because of the enhanced descending input to the alpha‐motor neurons that innervate the pDF.

However, it should be noted that among the 4 primary outcomes, the between‐groups differences could only be shown in pDF strength. Bi‐TENS+TOT was not superior to Uni‐TENS+TOT in improving the pPF strength, pKE, and pKF peak torque. This might be because TENS was applied to stimulate the common peroneal nerve only. Kaelin‐Lang and colleagues[49](#jah32954-bib-0049){ref-type="ref"} demonstrated that 2 hours of cutaneous electrical stimulation over the ulnar nerve at the wrist level increased the motor evoked potentials of the abductor digiti minimi muscle in response to focal transcranial magnetic stimulation in healthy adults.[49](#jah32954-bib-0049){ref-type="ref"} However, no significant change was shown in the motor evoked potentials of the abductor pollicis brevis muscle, which was innervated by the median nerve. Results of that study[49](#jah32954-bib-0049){ref-type="ref"} indicated that cutaneous electrical stimulation over a peripheral nerve increases the focal corticospinal excitability of the muscles innervated by the nerve being stimulated. The ankle plantarflexor, knee flexor and extensor were predominantly innervated by the tibial nerve, and sciatic and femoral nerves, respectively. The change in the pPF strength, pKF, and pKE peak torque might be attributable to the effects of TOT, but not the effects of TENS.

Consistent with previous results,[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} our results demonstrate significant within‐group improvement in pDF strength in both the Bi‐TENS and Uni‐TENS groups after 20 sessions of intervention. The mechanism that underlies the improved motor function in paretic limbs after TENS treatment is multifactorial; it involves alleviation of the hyperexcitability of alpha motor neurons,[9](#jah32954-bib-0009){ref-type="ref"}, [11](#jah32954-bib-0011){ref-type="ref"} reduction of intracortical inhibition,[12](#jah32954-bib-0012){ref-type="ref"} and enhancement of corticomuscular functional connectivity.[13](#jah32954-bib-0013){ref-type="ref"} Several clinical studies have demonstrated that the hyperexcitability of the alpha motor neurons that innervate the spastic ankle plantarflexor could be reduced by an increase in presynaptic inhibition after repetitive TENS.[9](#jah32954-bib-0009){ref-type="ref"}, [11](#jah32954-bib-0011){ref-type="ref"} Levin and Huichan reported that the ankle plantarflexor stretch reflex amplitude, as measured by the magnitude of integrated electromyography, was reduced significantly after a 3‐week regimen of repetitive TENS over the common peroneal nerve but not after placebo‐TENS stimulation.[9](#jah32954-bib-0009){ref-type="ref"} Chen and colleagues demonstrated that the H‐reflex latency of pPF was lengthened significantly after 6 weeks of TENS stimulation over the Achilles muscle--tendon junction but not after placebo‐TENS stimulation.[11](#jah32954-bib-0011){ref-type="ref"}

Other neurophysiological studies have demonstrated that repetitive cutaneous electrical stimulation could lead to a reduction in intracortical inhibition[12](#jah32954-bib-0012){ref-type="ref"} and enhancement of cortical and neuromuscular coupling[13](#jah32954-bib-0013){ref-type="ref"} at the cortical level, which might explain the improvement of motor function after TENS combined with TOT. Celnik and colleagues[12](#jah32954-bib-0012){ref-type="ref"} applied cutaneous electrical stimulation on the ulnar and radial nerves of the paretic upper limb for 2 hours before training of hand function. Their results showed a significant reduction of the short‐interval intracortical inhibition and significant improvement in the Jebsen‐Taylor Hand Function Test score in 9 subjects with subacute stroke,[12](#jah32954-bib-0012){ref-type="ref"} whereas no such change was seen after sham stimulation.

In addition, Lai and colleagues[13](#jah32954-bib-0013){ref-type="ref"} reported that 40 minutes of cutaneous electrical stimulation applied over the median nerve on the paretic hand could augment electroencephalography--electromyography coherence in 9 subjects with chronic stroke. The electroencephalography‐electromyography coherence, which refers to the synchronization of the oscillatory activities of the electromyography and electroencephalography signals, was used to assess the level of cortical and neuromuscular coupling. It has been reported that a low‐to‐high shift of the electroencephalography‐electromyography coherence frequency is a clinical indicator of motor recovery after stroke.[50](#jah32954-bib-0050){ref-type="ref"} Lai and colleagues[13](#jah32954-bib-0013){ref-type="ref"} showed that the electroencephalography‐electromyography coherence in the high‐frequency band (\>30 Hz) had increased significantly after repetitive TENS.

Moreover, motor control, as measured by the percentage of force deviation in maintaining a steady force output, was also improved after cutaneous electrical stimulation.[13](#jah32954-bib-0013){ref-type="ref"} Studies have found that Uni‐TENS augments the effects of TOT in subjects with stroke.[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"}, [51](#jah32954-bib-0051){ref-type="ref"} It has been suggested that the occurrence of motor cortex reorganization is likely suppressed by inhibitory mechanisms under normal conditions and that the release of intracortical inhibition might facilitate motor learning.[52](#jah32954-bib-0052){ref-type="ref"}, [53](#jah32954-bib-0053){ref-type="ref"} This notion was supported by the fact that reorganization of the motor representation area can be induced rapidly in rats when intracortical inhibition is blocked with drugs.[52](#jah32954-bib-0052){ref-type="ref"} Celnik and colleagues[12](#jah32954-bib-0012){ref-type="ref"} used transcranial magnetic stimulation to investigate the effects of cutaneous electrical stimulation on the level of corticospinal excitability in subjects with stroke. In this crossover‐designed study, subjects with stroke received 2 hours of sub--motor threshold cutaneous electrical stimulation on both ulnar and radial nerves or received placebo stimulation before 1 hour of hand function training. Cutaneous electrical stimulation led to no change in the resting motor threshold recorded from the first dorsal interosseous muscle, but it did reduce the short‐interval intracortical inhibition in 9 subjects with subacute stroke.[12](#jah32954-bib-0012){ref-type="ref"} In addition, the reduction of intracortical inhibition has been demonstrated during motor skill acquisition of a wrist flexion--extension waveform‐tracking task in healthy adults,[53](#jah32954-bib-0053){ref-type="ref"} and the enhanced cortical and neuromuscular coupling after TENS led to better motor control.[13](#jah32954-bib-0013){ref-type="ref"} Thus, repetitive TENS potentially optimizes the participants\' performance and augments the training effects of TOT.

Because a "pure" TOT control group was not incorporated in this study, the therapeutic effects of TOT could not be determined. However, the effects of placebo‐TENS+TOT and Uni‐TENS+TOT have been investigated in our laboratory.[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} With a training protocol and selection criteria similar to those for the participants with stroke, the results of our previous study[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} showed that placebo‐TENS+TOT led to greater improvement in paretic ankle dorsiflexion and plantarflexion strength[4](#jah32954-bib-0004){ref-type="ref"} than that seen in a control group without active treatment. Moreover, Uni‐TENS applied over the paretic limb combined with TOT was superior to TENS alone, placebo‐TENS+TOT, and control without any active treatment in improving ankle muscle strength[4](#jah32954-bib-0004){ref-type="ref"} in subjects with stroke.

Our stimulation protocol was based on the findings of our previous studies that had effectively demonstrated improvement in lower limb motor function in subjects with stroke.[1](#jah32954-bib-0001){ref-type="ref"}, [4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"}, [9](#jah32954-bib-0009){ref-type="ref"}, [10](#jah32954-bib-0010){ref-type="ref"}, [54](#jah32954-bib-0054){ref-type="ref"} The 100‐Hz stimulation frequency was chosen because previous studies have demonstrated that this frequency reduces the amplitude of the H‐reflex,[9](#jah32954-bib-0009){ref-type="ref"} lengthens the stretch reflex latencies,[10](#jah32954-bib-0010){ref-type="ref"} and enhances walking capacity[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"}, [54](#jah32954-bib-0054){ref-type="ref"} in subjects with stroke. It has been reported that 30 minutes of TENS applied over the deep peroneal nerve of the paretic leg with a stimulation frequency of 200 Hz led to a greater increase of presynaptic Ia inhibition than 50 and 100 Hz in 20 subjects with chronic stroke.[55](#jah32954-bib-0055){ref-type="ref"} However, no randomized controlled trial has supported the clinical efficacy of a 200‐Hz stimulation frequency. As for the stimulation duration, Laddha and colleagues[54](#jah32954-bib-0054){ref-type="ref"} compared the effects of 30 minutes versus 60 minutes of TENS applied over the common peroneal nerve combined with TOT. Although the pPF spasticity was reduced in both groups, their results indicated that 60 minutes of TENS combined with TOT was superior to 30 minutes of TENS combined with TOT in reducing ankle clonus in subjects with stroke.

The TOT program adopted the specificity of training principles by ensuring that the force generated by the muscles is directly related to functional movement.[4](#jah32954-bib-0004){ref-type="ref"} The TOT protocol for this study was adopted from that in our previous study,[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} which demonstrated that a combination of placebo‐TENS and TOT outperformed a control group with no active treatment in isometric pDF and pPF strength[4](#jah32954-bib-0004){ref-type="ref"} and TUG completion time.[5](#jah32954-bib-0005){ref-type="ref"} The improvement in muscle strength after TOT could be attributed to an increase in muscle volume[56](#jah32954-bib-0056){ref-type="ref"} and recruitment of alternative neural substrate.[57](#jah32954-bib-0057){ref-type="ref"} Ryan and colleagues reported that 12 weeks of resistive training of the knee extensors increased the paretic thigh\'s cross‐sectional area and volume by ≈15% and increased the knee extension strength by 56%.[56](#jah32954-bib-0056){ref-type="ref"} Luft and colleagues[57](#jah32954-bib-0057){ref-type="ref"} reported that 6 months of treadmill exercise induced greater activation in multiple brain regions than passive stretching in subjects with stroke. These brain areas included the posterior cerebellar lobe, the midbrain, and the ipsilesional postcentral and superior frontal gyri, which were the areas that potentially mediated the walking‐related activities. In addition, ambulation functions could be facilitated because these exercises required the subjects to activate the muscle in the position in which the muscles normally functioned.

Unlike our previous studies[4](#jah32954-bib-0004){ref-type="ref"}, [5](#jah32954-bib-0005){ref-type="ref"} in which TENS was applied before TOT, the TENS treatment in this study was applied concurrently with TOT. Two studies have reported that simultaneous TENS and TOT augment balance performance[7](#jah32954-bib-0007){ref-type="ref"} and trunk control[51](#jah32954-bib-0051){ref-type="ref"} in subjects with stroke. Khaslavskaia and colleagues[58](#jah32954-bib-0058){ref-type="ref"} reported that cutaneous electrical stimulation over the common peroneal nerve for 30 minutes enhanced corticospinal excitability for up to 110 minutes in healthy adults, which supported the application of TENS before TOT. However, Khaslavskaia and Sinkjaer[59](#jah32954-bib-0059){ref-type="ref"} reported that cutaneous electrical stimulation applied over the common peroneal nerve combined with simultaneous active ankle dorsiflexion exercise for 30 minutes increased the motor evoked potentials recorded from the tibialis anterior by 66% in 8 healthy adults, whereas cutaneous electrical stimulation alone increased the motor evoked potentials by only 38%.[59](#jah32954-bib-0059){ref-type="ref"} One of the advantages of the current TENS+TOT protocol is that it can significantly reduce the treatment duration, thus enhancing the cost‐effectiveness of the program and the compliance of the participants.

Secondary Outcomes {#jah32954-sec-0027}
------------------

The greater improvement in the TUG completion time after completion of 20 sessions of training could have been mediated by the improved pDF strength, because pDF strength has been reported to be a significant predictor of the TUG completion time (β=0.750).[60](#jah32954-bib-0060){ref-type="ref"} Moreover, the muscles of the nonparetic leg are also weakened in subjects with stroke.[61](#jah32954-bib-0061){ref-type="ref"} A previous study also reported that the nonparetic ankle contributed 55% to 89% to balance maintenance after perturbation,[62](#jah32954-bib-0062){ref-type="ref"} and a simulation study reported that an increase in nonparetic knee extension strength could enhance clearance of the paretic ankle during the swing phase of the paretic leg in a model of subjects with stroke.[63](#jah32954-bib-0063){ref-type="ref"} It is possible that Bi‐TENS also augments the training effects on the nonparetic leg and thus enhances the overall walking capacity. However, results of the current study showed that there was no significant between‐groups difference seen on nonparetic lower‐limb muscle strength, lower‐limb coordination, or dynamic standing balance after 20 sessions of training. Thus, it was unlikely that the improvement of nonparetic leg motor functions contributed to the improvement in walking capacity.

Although significant within‐group improvement was shown in lower‐limb coordination, dynamic standing balance, and balance performance, no significant between‐groups difference was seen in these outcomes. The LEMOCOT involves the coordinated movement of the knee flexor and extensor, which are predominantly innervated by the sciatic and femoral nerves. The ST and BBS evaluate trunk control, functional muscle strength in the legs, and anticipatory postural adjustment. The application of Bi‐TENS to the common peroneal nerve might only improve the motor outputs of muscles that are innervated by the superficial and deep peroneal nerves, including the ankle dorsiflexors and evertors. This finding might explain the lack of a between‐groups difference in plantarflexor strength or in the LEMOCOT, ST, or BBS scores.

Carryover Effects {#jah32954-sec-0028}
-----------------

The paretic lower‐limb coordination, dynamic standing balance, functional mobility, and balance performance showed no significant deterioration at 3 months after training in either group. The pPF strength was reduced significantly in follow‐up assessment in both groups. These findings are suggestive that the detraining effect had a strong influence on muscle strength but not on functional performance. Häkkinen and colleagues[64](#jah32954-bib-0064){ref-type="ref"} reported a significant reduction in the cross‐sectional area of the quadriceps and reduction in the isometric strength of knee extensors up to 6% after 3 weeks and 12% after 24 weeks of detraining in healthy adults. However, the functional outcomes, including walking speed and jumping height, showed no significant change. Those results indicated that the improved neuromuscular control was maintained even after detraining, and partially compensated for the loss in muscle strength, which might explain the preservation of lower‐limb functions.

Limitations {#jah32954-sec-0029}
-----------

This study has several limitations that must be considered. First, because the primary objective of this study is to compare Bi‐TENS and Uni‐TENS in improving motor function in stroke survivors, there was no pure TOT group or control group without active treatment to delineate the treatment effects of TENS and TOT. Second, the neurophysiological mechanisms that mediate the effects of Bi‐TENS and Uni‐TENS remain unclear. Future studies are necessary to investigate the differential effects of Bi‐TENS and Uni‐TENS on cortical function. Third, the therapist who supervised the training was not blinded to the group allocations, but the standardized treatment protocol could have minimized the bias. Fourth, selection bias might have existed because all participants in this study were community‐dwelling and self‐selected to participate. Thus, they were likely to be more motivated and to have a better mobility level than those who declined to participate. Recruitment of subjects with poor mobility should be considered in a future study. Fifth, we did not measure the actual repetition of movement accomplished by the subjects in each exercise. The actual dosage of exercise could vary considerably among subjects. The number of repetitions, instead of exercise duration, could be used as an indicator of exercise dosage in a future study. Finally, the follow‐up period was limited to 3 months after training because of limitations in resources. A longer‐term carryover effect cannot be determined.

Conclusions and Clinical Implications {#jah32954-sec-0030}
=====================================

This study demonstrates that Bi‐TENS applied on the common peroneal nerves combined with lower‐limb TOT induces greater improvement in pDF strength beginning after 10 sessions and greater improvement in TUG completion time after 20 sessions than Uni‐TENS combined with TOT, while Bi‐TENS showed no additional advantage in improving pPF strength and knee muscle strength. Both Bi‐TENS+TOT and Uni‐TENS+TOT induced significant within‐group improvements in paretic ankle strength, lower‐limb coordination, dynamic standing balance, functional mobility, and balance performance in subjects with chronic stroke after 20 sessions of training. The training effects in both groups were maintained for 3 months. The results of this study suggest that Bi‐TENS+TOT is superior to Uni‐TENS+TOT for improving the TUG completion time in subjects with chronic stroke, but the 2 training protocols seem to demonstrate similar efficacy on the LEMOCOT score, ST score, and BBS score. The subjects who participated in this study had a relatively high level of motor function, so the results may not be applicable to subjects with limited motor function.
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